⚠️
Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Elevated cost per beneficiaryElevated antipsychotic prescribing (65+)Extreme fills per patient
Risk indicators are statistical patterns, not allegations. Learn more
44,853
Total Claims
$5.8M
Drug Cost
775
Beneficiaries
$7,537
Cost/Patient
Risk Score Breakdown 15/100
Low (0)Moderate (15)Elevated (30)High (50+)
Elderly antipsychotic prescribing+5
High fills per patient+5
Cost per patient outlier+3
Score components are additive. Read full methodology
Peer Comparison vs. 9,082 Pulmonary Disease providers
+47%
Cost per patient vs peers
$7,537 vs $5,138 avg
-78%
Brand preference vs peers
13.5% vs 61.4% avg
Brand vs Generic
87% generic
Brand: 5,743 claims · $3.7M
Generic: 36,849 claims · $2.1M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 827 | $681K |
| Famotidine | 2,083 | $475K |
| Diclofenac Potassium | 123 | $470K |
| Empagliflozin | 287 | $282K |
| Dapagliflozin Propanediol | 276 | $220K |
| Semaglutide | 168 | $204K |
| Insulin Aspart | 193 | $188K |
| Budesonide/Formoterol Fumarate | 333 | $179K |
| Clemastine Fumarate | 21 | $171K |
| Dulaglutide | 122 | $169K |
| Sitagliptin Phos/Metformin Hcl | 189 | $152K |
| Insulin Glargine,hum.Rec.Anlog | 346 | $152K |
| Apixaban | 169 | $152K |
| Meloxicam, Submicronized | 144 | $137K |
| Fluticasone Propion/Salmeterol | 171 | $110K |
Prescribing Profile
Patient Profile
69
Avg Age
38%
Female
1.33
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About